Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

591
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
591
Pulmonary Function Tests01:25

Pulmonary Function Tests

760
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
760
Gene Therapy00:59

Gene Therapy

27.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

340
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
340
Functional Groups02:45

Functional Groups

87.7K
Functional groups are a group of atoms with characteristic properties, which when linked to the carbon skeleton of a molecule, alter the properties of that molecule. For example, the presence of certain functional groups on a molecule will make them hydrophilic, whereas others will make them hydrophobic. These functional groups are an indispensable part of organic chemistry and important components of biological molecules, such as carbohydrates, proteins, lipids, and nucleic acids. Each...
87.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discharge Prescription of Renin-Angiotensin System Inhibitors After Hyperkalemia and Its Association With Mortality and Dialysis Outcomes.

Cureus·2026
Same author

Protein Intake and Kidney Outcomes in Nondialysis Chronic Kidney Disease Over 15 Years.

JAMA network open·2026
Same author

The effect of hyperbaric oxygen therapy on sleep quality across diverse patient populations.

Frontiers in neurology·2026
Same author

Hyperbaric oxygen therapy for post-partum bell's palsy associate with anti-phospholipid syndrome: a case report, literature review, and mechanistic insights.

Frontiers in rehabilitation sciences·2026
Same author

The Incidence and Risk Factors of Gout in Non-dialysis Chronic Kidney Disease Patients With Asymptomatic Hyperuricemia.

Kidney medicine·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Jan 21, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

534

Hyperbaric oxygen therapy effects on pulmonary functions: a prospective cohort study.

Amir Hadanny1,2,3, Tal Zubari4, Liat Tamir-Adler4

  • 1The Sagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Zerifin, Israel. Amir.had@gmail.com.

BMC Pulmonary Medicine
|August 15, 2019
PubMed
Summary

Hyperbaric oxygen therapy (HBOT) is safe for pulmonary functions. This study found no significant adverse effects on lung function after 60 HBOT sessions, with slight improvements in FVC and PEF.

Keywords:
HBOTHyperbaric oxygenOxygen toxicityPFTPulmonary function

More Related Videos

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

737
Studying Cavitation Enhanced Therapy
07:36

Studying Cavitation Enhanced Therapy

Published on: April 9, 2021

5.7K

Related Experiment Videos

Last Updated: Jan 21, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

534
Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
10:03

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension

Published on: June 27, 2025

737
Studying Cavitation Enhanced Therapy
07:36

Studying Cavitation Enhanced Therapy

Published on: April 9, 2021

5.7K

Area of Science:

  • Pulmonary Medicine
  • Hyperbaric Medicine
  • Respiratory Physiology

Background:

  • Oxygen toxicity is a potential side effect of hyperbaric oxygen therapy (HBOT).
  • Previous studies indicated mild pulmonary function reductions after HBOT.
  • Updated data on the pulmonary effects of current HBOT protocols are lacking.

Purpose of the Study:

  • To evaluate the effect of HBOT on pulmonary functions in patients undergoing the current HBOT protocol.
  • To assess safety and identify any changes in lung function parameters.

Main Methods:

  • Prospective analysis of patients (≥18 years) receiving 60 daily HBOT sessions (90 min, 100% O2, 2 ATA, 5 min air breaks every 20 min, 5 days/week).
  • Pulmonary functions including forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1), and peak expiratory flow rate (PEF) were measured at baseline and post-HBOT.
  • Analysis included patients undergoing treatment between 2016 and 2018.

Main Results:

  • No significant changes were observed in FEV1, FEV1/FVC ratio, and FEF25-75% post-HBOT compared to baseline.
  • A statistically significant, though not clinically relevant, increase in FVC (0.1 L) and PEF (0.5 L) was noted.
  • The study cohort comprised 88 patients, with a mean age of 60.36 years; 94.3% had no prior pulmonary disease.

Conclusions:

  • Repeated hyperbaric oxygen exposure using the current HBOT protocol is safe for pulmonary functions.
  • A modest, statistically significant but not clinically relevant improvement in PEF and FVC was observed in patients without chronic lung diseases.
  • The findings suggest HBOT is well-tolerated regarding lung function in this patient group.